Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database.
<h4>Background</h4>Oral anticoagulants (OACs) mitigate the risk of stroke in atrial fibrillation (AF) patients.<h4>Objective</h4>Elderly AF patients who were treated with OACs (apixaban, dabigatran, edoxaban, rivaroxaban, or warfarin) were compared against AF patients who wer...
Main Authors: | Muhammad Bilal Munir, Patrick Hlavacek, Allison Keshishian, Jennifer D Guo, Rajesh Mallampati, Mauricio Ferri, Cristina Russ, Birol Emir, Matthew Cato, Huseyin Yuce, Jonathan C Hsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0263903 |
Similar Items
-
Delayed treatment initiation of oral anticoagulants among Medicare patients with atrial fibrillation
by: Xuemei Luo, et al.
Published: (2024-03-01) -
Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
by: Inmaculada Hernandez, et al.
Published: (2019-06-01) -
Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients
by: Steven Deitelzweig, et al.
Published: (2021-03-01) -
Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure.
by: Alpesh Amin, et al.
Published: (2019-01-01) -
Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease
by: Alexandros Briasoulis, et al.
Published: (2018-04-01)